The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice
Open accessAbstract
Adiponectin has recently been shown to be a promising candidate for the treatment of obesity-associated metabolic syndromes. Replenishment of recombinant adiponectin in mice can decrease hyperglycemia, reverse insulin resistance, and cause sustained weight loss without affecting food intake. Here we report its potential roles in alcoholic and nonalcoholic fatty liver diseases in mice. Circulating concentrations of adiponectin decreased significantly following chronic consumption of high-fat ethanol-containing food. Delivery of recombinant adiponectin into these mice dramatically alleviated hepatomegaly and steatosis (fatty liver) and also significantly attenuated inflammation and the elevated levels of serum alanine aminotransferase. These therapeutic effects resulted partly from the ability of adiponectin to increase carnitine palmitoyltransferase I activity and enhance hepatic fatty acid oxidation, while it decreased the activities of two key enzymes involved in fatty acid synthesis, including acetyl-CoA carboxylase and fatty acid synthase. Furthermore, adiponectin treatment could suppress the hepatic production of TNF-alpha and plasma concentrations of this proinflammatory cytokine. Adiponectin was also effective in ameliorating hepatomegaly, steatosis, and alanine aminotransferase abnormality associated with nonalcoholic obese, ob/ob mice. These results demonstrate a novel mechanism of adiponectin action and suggest a potential clinical application of adiponectin and its agonists in the treatment of liver diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Fruebis, J., Tsao, T., Javorschi, S., Ebbets-Reed, D., Erickson, M., Yen, F. T., Bihain, B. E., & Lodish, H. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041591798 · Cited by 1,985
Yokota, T., Oritani, K., Takahashi, I., Ishikawa, J., Matsuyama, A., Ouchi, N., Kihara, S., Funahashi, T., Tenner, A. J., Tomiyama, Y., et al. (2000) · Blood · doi:10.1182/blood.v96.5.1723 · Cited by 1,297
Ouchi, N., Kihara, S., Arita, Y., Nishida, M., Matsuyama, A., Okamoto, Y., Ishigami, M., Kuriyama, H., Kishida, K., Nishizawa, H., et al. (2001) · Circulation · doi:10.1161/01.cir.103.8.1057 · Cited by 1,277
ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism
Berg, A. H., Combs, T. P., & Scherer, P. E. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00524-0 · Cited by 1,213
Disruption of Adiponectin Causes Insulin Resistance and Neointimal Formation
Kubota, N., Terauchi, Y., Yamauchi, T., Kubota, T., Moroi, M., Matsui, J., Eto, K., Yamashita, T., Kamon, J., Satoh, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200251200 · Cited by 1,208
Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.
Wanless, I. R., & Lentz, J. S. (1990) · Hepatology · doi:10.1002/hep.1840120505 · Cited by 1,191
Disruption of adiponectin causes insulin resistance and neointimal formation
Froguel, P. (2002) · HAL · Cited by 1,134
Chitturi, S., Abeygunasekera, S., Farrell, G. C., Holmes-Walker, J., Hui, J. M., Fung, C., Karim, R., Lin, R., Samarasinghe, D., Liddle, C., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.30692 · Cited by 1,122
Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B. C., & Matsuzawa, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1126 · Cited by 1,072
AMP-activated protein kinase, a metabolic master switch: possible roles in Type 2 diabetes
Winder, W. W., & Hardie, D. G. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.1.e1 · Cited by 1,000
Cytokines in Alcoholic and Nonalcoholic Steatohepatitis
Tilg, H., & Diehl, A. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432007 · Cited by 948
Endogenous glucose production is inhibited by the adipose-derived protein Acrp30
Combs, T. P., Berg, A. H., Obici, S., Scherer, P. E., & Rossetti, L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14120 · Cited by 935
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., DeSimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Nonalcoholic Steatohepatitis: Definition and Pathology
Brunt, E. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12925 · Cited by 911
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
Yamauchi, T., Kamon, J., Waki, H., Imai, Y., Shimozawa, N., Hioki, K., Uchida, S., Ito, Y., Takakuwa, K., Matsui, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209033200 · Cited by 911
Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice
Yin, M., Wheeler, M. D., Kono, H., Bradford, B. U., Gallucci, R. M., Luster, M. I., & Thurman, R. G. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70354-9 · Cited by 701
Metformin in non-alcoholic steatohepatitis.
Marchesini, G., Bianchi, G., Tomassetti, S., Zoli, M., & Melchionda, N. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06042-1 · Cited by 682
Metformin reverses fatty liver disease in obese, leptin-deficient mice.
Lin, H. Z., Yang, S. Q., Chuckaree, C., Kuhajda, F., Ronnet, G., & Diehl, A. M. (2000) · Nature Medicine · doi:10.1038/79697 · Cited by 673
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 673
Etiopathogenesis of Nonalcoholic Steatohepatitis
Chitturi, S., & Farrell, G. C. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12927 · Cited by 661
Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes
Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., & Paschke, R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.6307 · Cited by 655
Shapiro, L., & Scherer, P. E. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70133-2 · Cited by 655
Liver Pathology and the Metabolic Syndrome X in Severe Obesity
Marceau, P. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.5.1513 · Cited by 635
Inactivation of Kupffer cells prevents early alcohol-induced liver injury
Adachi, Y., Bradford, B. U., Gao, W., Bojes, H. K., & Thurman, R. G. (1994) · Hepatology · doi:10.1002/hep.1840200227 · Cited by 556
You, M., Fischer, M., Deeg, M. A., & Crabb, D. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202411200 · Cited by 543
Resistin and obesity-associated insulin resistance
Steppan, C. M., & Lazar, M. A. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(01)00522-7 · Cited by 526
The OB Protein (Leptin) Pathway - A Link Between Adipose Tissue Mass and Central Neural Networks
Campfield, L., Smith, F., & Burn, P. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979867 · Cited by 499
Iimuro, Y., Gallucci, R. M., Luster, M. I., Kono, H., & Thurman, R. G. (1997) · Hepatology · doi:10.1002/hep.510260621 · Cited by 497
Cytokines in Alcoholic Liver Disease
McClain, C., Barve, S., Deaciuc, I., Kugelmas, M., & Hill, D. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007110 · Cited by 399
Effects of ethanol on lipid metabolism.
Baraona, E., & Lieber, C. S. (1979) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)40613-3 · Cited by 392
Wang, Y., Xu, A., Knight, C., Xu, L. Y., & Cooper, G. J. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200601200 · Cited by 342
Self-citationTroglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Alcoholic steatosis and steatohepatitis.
Maher, J. J. (2002) · PubMed · Cited by 315
Cytokine regulation of liver injury and repair
Diehl, A. M. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017411.x · Cited by 301
Fasshauer, M., Klein, J., Neumann, S., Eszlinger, M., & Paschke, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02960-x · Cited by 261
Chang, H.-C., Seidman, I., Teebor, G., & Lane, M. D. (1967) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(67)90369-5 · Cited by 251
Kudo, N., Gillespie, J. G., Kung, L., Witters, L. A., Schulz, R., Clanachan, A. S., & Lopaschuk, G. D. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00013-6 · Cited by 245
Siler, S. Q., Neese, R. A., & Hellerstein, M. K. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.5.928 · Cited by 231
Alcoholic liver disease: new insights into mechanisms and preventative strategies
Stewart, S., Jones, D., & Day, C. P. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02096-2 · Cited by 187
IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines
Diehl, A. M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00384.2001 · Cited by 178
Delporte, M., Funahashi, T., Takahashi, M., Matsuzawa, Y., & Brichard, S. M. (2002) · Biochemical Journal · doi:10.1042/bj20020610 · Cited by 163
Change in Expression of GBP28/Adiponectin in Carbon Tetrachloride-Administrated Mouse Liver
Yoda-Murakami, M., Taniguchi, M., Takahashi, K., Kawamata, S., Saito, K., Choi-Miura, N.-H., & Tomita, M. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5134 · Cited by 127
Lin, H., Yang, S., Zeldin, G. A., & Diehl, A. M. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb04008.x · Cited by 121
Enomoto, N., Takei, Y., Hirose, M., Ikejima, K., Miwa, H., Kitamura, T., & Sato, N. (2002) · Gastroenterology · doi:10.1053/gast.2002.34161 · Cited by 90
A Role for Interleukin-10 in Alcohol-Induced Liver Sensitization to Bacterial Lipopolysaccharide
Hill, D. B., D'Souza, N. B., Lee, E. Y., Burikhanov, R., Deaciuc, I. V., & de Villiers, W. J. S. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02434.x · Cited by 81
A NEW ORAL LOW-CARBOHYDRATE ALCOHOL LIQUID DIET PRODUCING LIVER LESIONS: A PRELIMINARY ACCOUNT
Lindros, K. O., & Järveläinen, H. A. (1998) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a008403 · Cited by 72
Molecular Pathology and Clinical Aspects of Alcohol-Induced Tissue Injury
Molina, P. E., McClain, C. J., Valla, D. C., Guidot, D. M., Diehl, A. M., Lang, C. H., & Neuman, M. G. (2002) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02440.x · Cited by 71
Järveläinen, H. A., Fang, C., Ingelman‐Sundberg, M., Lukkari, T. A., Sippel, H. W., & Lindros, K. O. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80094-x · Cited by 66
Measurement of acetyl-CoA carboxylase activity in isolated hepatocytes
Bijleveld, C., & Geelen, M. J. H. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90231-1 · Cited by 63
Lange, K. (2002) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2002.282.1.c1 · Cited by 58
Mechanisms of alcohol-induced hepatotoxicity studies in rats
Thurman, R. G. (1999) · Frontiers in bioscience · doi:10.2741/a478 · Cited by 57
Multiple biochemical effects in the pathogenesis of alcoholic fatty liver
Eaton, S. D., Record, C. O., & Bartlett, K. (1997) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1997.1780727.x · Cited by 49
Mechanisms of alcohol-induced hepatotoxicity: studies in rats
R.G., R. G. T. (1999) · Frontiers in bioscience · doi:10.2741/thurman · Cited by 43
Wilkes, J. J., DeForrest, L. L., & Nagy, L. E. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.3.e477 · Cited by 39
Piot, C., Hocquette, J.-F. J.-F., Veerkamp, J. H., Durand, D., & Bauchart, D. (1999) · British Journal Of Nutrition · doi:10.1017/s0007114599001506 · Cited by 29
Guzmán, M., & Geelen, M. J. H. (1988) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(88)90065-3 · Cited by 23
Guzmán, M., & Geelen, M. J. H. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90193-3 · Cited by 12
Guzmán, M., & Castro, J. M. (1989) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(89)90358-5 · Cited by 10
Adamo, S., Siliprandi, N., Lisa, F. D., Carrara, M., Azzurro, M., Sartori, G., Vita, G., & Ghidini, O. (1988) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1988.tb00259.x · Cited by 10
Research works printed but not linked: 4
- Kubota, 2002, J. Biol. Chem., 277, 35863
- Wilkes, 1996, Am. J. Physiol., 271, E477
- Winder, 1999, Am. J. Physiol., 277, E1
- Funabiki, 2002, Diabetes., 51(Suppl. 2), 32a
Cited by
Adipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Inflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Adipocytokines: mediators linking adipose tissue, inflammation and immunity
Tilg, H., & Moschen, A. R. (2006) · Nature Reviews Immunology · doi:10.1038/nri1937 · Cited by 3,188
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Buzzetti, E., Pinzani, M., & Tsochatzis, E. A. (2016) · Metabolism · doi:10.1016/j.metabol.2015.12.012 · Cited by 3,119
Adiponectin and Adiponectin Receptors
Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634
Metadata
- Authors
- Xu, A., Wang, Y., Keshaw, H., Xu, L. Y., Lam, K. S. L., & Cooper, G. J. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2003-07-01
- Volume
- 112
- Issue
- 1
- Pages
- 91-100
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2120590109
- Cited by
- 1,296
- References
- 68
- FWCI
- 47.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.